09.11.2015 • Topics

The Centre-Val de Loire Region is a Magnet for Foreign Investors

© Fredex - Fotolia.com
© Fredex - Fotolia.com

In 2014, 25 projects of foreign companies in the Centre-Val de Loire region were listed and a total of 2.115 jobs were created/maintained. These numbers exceeded the previous average of the 2010-2014 period considerably. Regarding the type of investments made, site extensions and company takeovers are now more common than start-ups from scratch.

Europe is still the leading supplier of investment projects and jobs for the Centre-Val de Loire region (40%), followed by North America with 28% of projects. But both of these regions are steadily losing ground to the emerging economies, from which 6 out of 25 projects came in 2014.

In 2014 two-thirds of investment projects and 80% of the jobs created/maintained in the Centre-Val de Loire region involving foreign companies concerned production roles. The region is now the leader for new production jobs in mainland France (1,769 announced in 2014). The projects listed reflect the region's top industrial activities: over the 2010-2014 period, almost a third of projects and jobs created/maintained concerned the pharmaceuticals, mechanical equipment, plastics processing and household equipment sectors.

Logistics has also been well represented with the region's prime geographical location and outstanding transport infrastructure having a positive impact.

Interview

The UK Chemical Supply Chain
Trade and Competitiveness

The UK Chemical Supply Chain

The CBA, led by CEO Tim Doggett, is steering the UK chemical supply chain through trade uncertainty, sustainability pressures and logistics challenges, as he explains in this interview with CHEManager.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read